Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial...

Area of Science:

• Cardiovascular Surgery
• Vascular Biology
• Medical Interventions

Background:

• Hypercholesterolemia is a known risk factor for atherosclerosis in coronary arteries and bypass grafts.
• Limited data exist on hypercholesterolemia's specific impact on bypass graft disease post-coronary artery bypass grafting (CABG).

Purpose of the Study:

• To investigate the influence of preoperative hypercholesterolemia on the development of bypass graft disease.
• To evaluate the efficacy of preoperative lipid control in patients undergoing CABG.

Main Methods:

• A 1-year clinical and angiographic follow-up study was conducted.
• Patients were categorized into three groups based on preoperative cholesterol levels: uncontrolled hypercholesterolemia (Group 1), controlled hypercholesterolemia (Group 2), and normal cholesterol (Group 3).
• Demographics, angiography, and operation data were analyzed.

Main Results:

• Group 1 (uncontrolled hypercholesterolemia) exhibited a significantly higher incidence of graft lesions and required more interventions compared to Group 2 (controlled hypercholesterolemia).
• Sequential vein bypass grafts demonstrated better outcomes than single vein grafts.
• Preoperative lipid control was associated with reduced vein graft obstructive disease.

Conclusions:

• Uncontrolled hypercholesterolemia directly impacts the outcome of CABG procedures.
• Preoperative lipid management with statins is strongly recommended to mitigate the development of vein graft disease.
• Effective lipid control significantly improves long-term results after CABG.